Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Primary Biliary Cholangitis
In brief
The primary objective of this study is to evaluate the safety and tolerability of cilofexor in adults with primary biliary cholangitis (PBC).
Key facts
- Study ID
- NCT02943447
- Run by
- Gilead Sciences
- People needed
- 71
- Starts
- 2016-12-01
- Expected to finish
- 2019-09-04
- Last updated by the study team
- 2020-09-22
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Sacramento, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Lakewood Rch, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Marietta, Georgia, United States
- Study site — Saint Paul, Minnesota, United States
- Study site — Arlington, Texas, United States
- Study site — Dallas, Texas, United States
- Study site — Dallas, Texas, United States
- Study site — Houston, Texas, United States
- Study site — Charlottesville, Virginia, United States
- Study site — Newport News, Virginia, United States
- Study site — Seattle, Washington, United States
- Study site — Vienna, State of Vienna, Austria
- Study site — Graz, Styria, Austria
- Study site — Calgary, Alberta, Canada
- Study site — Vancouver, British Columbia, Canada
- Study site — Vancouver, British Columbia, Canada
- Study site — Winnipeg, Manitoba, Canada
- Study site — Toronto, Ontario, Canada
- Study site — Vaughan, Ontario, Canada
- Study site — Birmingham, England, United Kingdom
- Study site — London, England, United Kingdom
- Study site — London, England, United Kingdom
- Study site — Norwich, England, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.